Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status
Crossref DOI link: https://doi.org/10.1007/s11523-015-0403-8
Published Online: 2015-12-15
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huguet, Florence
Fernet, Marie
Giocanti, Nicole
Favaudon, Vincent
Larsen, Annette K.
Funding for this research was provided by:
Nuovo Soldati Research Foundation (2010)
Text and Data Mining valid from 2015-12-15